These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32520156)

  • 21. Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain Imaging.
    Di Nunzio D; Recupero A; de Gregorio C; Zito C; Carerj S; Di Bella G
    Curr Cardiol Rep; 2019 Feb; 21(2):7. PubMed ID: 30747298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis.
    Cacciapuoti F
    J Echocardiogr; 2015 Sep; 13(3):84-9. PubMed ID: 26184746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of cardiac magnetic resonance imaging in identification of amyloid cardiomyopathy.
    Crean A; Merchant N
    Indian Heart J; 2004; 56(6):682-3. PubMed ID: 15751531
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
    Damy T; Jaccard A; Guellich A; Lavergne D; Galat A; Deux JF; Hittinger L; Dupuis J; Frenkel V; Rigaud C; Plante-Bordeneuve V; Bodez D; Mohty D
    Amyloid; 2016 Sep; 23(3):194-202. PubMed ID: 27647161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiac amyloidosis. Invasive and noninvasive diagnosis].
    Pinamonti B; Dreas L; Bussani R; Mestroni L; Silvestri F; Tanganelli P; Camerini F
    G Ital Cardiol; 1987 Dec; 17(12):1016-30. PubMed ID: 3503797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis of cardiac amyloidosis using magnetic resonance imaging: a new reliable, non-invasive technique to be validated].
    Sanzalone T; Thomson V; Dauphin R; Journe C; Berthezene Y
    Rev Med Interne; 2011 Oct; 32(10):633-7. PubMed ID: 21925775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.
    Mekinian A; Lions C; Leleu X; Duhamel A; Lamblin N; Coiteux V; De Groote P; Hatron PY; Facon T; Beregi JP; Hachulla E; Launay D;
    Am J Med; 2010 Sep; 123(9):864-8. PubMed ID: 20800158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac manifestations of amyloid disease.
    Rivera RJ; Vicenty S
    Bol Asoc Med P R; 2008; 100(4):60-70. PubMed ID: 19400531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel strategies for the diagnosis and treatment of cardiac amyloidosis.
    Palladini G; Milani P; Merlini G
    Expert Rev Cardiovasc Ther; 2015 Nov; 13(11):1195-211. PubMed ID: 26496239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Speckle tracking echocardiography in cardiac amyloidosis.
    Stricagnoli M; Cameli M; Incampo E; Lunghetti S; Mondillo S
    Heart Fail Rev; 2019 Sep; 24(5):701-707. PubMed ID: 30989593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive demonstration of cardiac involvement in acquired forms of systemic amyloidosis.
    Hind CR; Gibson DG; Lavender JP; Pepys MB
    Lancet; 1984 Jun; 1(8391):1417. PubMed ID: 6145870
    [No Abstract]   [Full Text] [Related]  

  • 32. Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis.
    Palladini G; Barassi A; Perlini S; Milani P; Foli A; Russo P; Albertini R; Obici L; Lavatelli F; Sarais G; Casarini S; Moratti R; Melzi d'Eril GV; Merlini G
    Amyloid; 2011 Dec; 18(4):216-21. PubMed ID: 22070520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current state of cardiac amyloidosis.
    Sharma N; Howlett J
    Curr Opin Cardiol; 2013 Mar; 28(2):242-8. PubMed ID: 23324855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
    Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
    Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of echocardiography in assessing cardiac amyloidoses: a systematic review.
    Koyama J; Minamisawa M; Sekijima Y; Kuwahara K; Katsuyama T; Maruyama K
    J Echocardiogr; 2019 Jun; 17(2):64-75. PubMed ID: 30741395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of strain indexes and prognosis of patients with cardiac amyloidosis with preserved LVEF by three-dimensional speckle tracking imaging].
    Yu ZH; Wu BF; Zhou YJ; Yan H; Zhu JH
    Zhonghua Yi Xue Za Zhi; 2018 Dec; 98(47):3842-3847. PubMed ID: 30585027
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent advances in the noninvasive strategies of cardiac amyloidosis.
    Zhao L; Fang Q
    Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Imaging technics in extra-cardiac thoracic amyloidosis].
    Hélénon O; Frija J; Yana C; Clauvel JP; Fromentin JC; Laval-Jeantet M
    J Radiol; 1989 Mar; 70(3):159-66. PubMed ID: 2659785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloidosis of the heart and respiratory system.
    Van Geluwe F; Dymarkowski S; Crevits I; De Wever W; Bogaert J
    Eur Radiol; 2006 Oct; 16(10):2358-65. PubMed ID: 16703313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac amyloidosis: approaches to diagnosis and management.
    Desai HV; Aronow WS; Peterson SJ; Frishman WH
    Cardiol Rev; 2010; 18(1):1-11. PubMed ID: 20010333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.